Foreign investors divested ₹4,521 crore from IT and ₹4,036 crore from healthcare stocks in the latter half of September. This selling was driven by concerns over US H-1B visa restrictions and new pharma tariffs, impacting export-oriented sectors. Overall, FPIs sold ₹19,647 crore across 15 sectors during the period.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO